Literature DB >> 2440675

Identification of 69-kd and 100-kd forms of 2-5A synthetase in interferon-treated human cells by specific monoclonal antibodies.

A G Hovanessian, A G Laurent, J Chebath, J Galabru, N Robert, J Svab.   

Abstract

Recently, the existence of 40-kd and 46-kd 2-5A synthetases in interferon-treated cells has been confirmed by cloning and characterization of cDNA corresponding to these small size enzymes. By the use of specific monoclonal antibodies, we describe here two forms of high mol. wt 2-5A synthetases of 69 and 100 kd in human cells. The monoclonal antibodies immunoprecipitate either a 69- or a 100-kd 2-5A synthetase. These purified 2-5A synthetases in immune complex preparations are active, i.e. addition of poly(I).poly(C) and ATP results in the synthesis of 2-5A. Both 2-5A synthetases are composed of several subspecies with similar isoelectric points in the range of 7-8 but have different subcellular localizations: 100-kd synthetase is recovered from the microsomal pellet whereas 69-kd synthetase is found to be associated with cell membranes as well as with the microsomal pellet. Different types of interferon-treated human cells express both or either forms of these enzymes. The 69- and 100-kd 2-5A synthetases were also identified by electrophoretic transfer immunoblot analysis using rabbit polyclonal antibodies against a synthetic peptide common on both 46- and 40-kd 2-5A synthetases. These results indicate that small and large size isozymes share a common peptide sequence.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2440675      PMCID: PMC553929          DOI: 10.1002/j.1460-2075.1987.tb02364.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  35 in total

1.  Interferon-regulated human 2-5A synthetase gene maps to chromosome 12.

Authors:  B R Williams; M E Saunders; H F Willard
Journal:  Somat Cell Mol Genet       Date:  1986-07

2.  Full-length sequence and expression of the 42 kDa 2-5A synthetase induced by human interferon.

Authors:  M Wathelet; S Moutschen; A Cravador; L DeWit; P Defilippi; G Huez; J Content
Journal:  FEBS Lett       Date:  1986-02-03       Impact factor: 4.124

3.  Two molecular weight forms of human 2',5'-oligoadenylate synthetase have different activation requirements.

Authors:  D H Ilson; P F Torrence; J Vilcek
Journal:  J Interferon Res       Date:  1986-02

4.  3' end structure of the human (2'-5') oligo A synthetase gene: prediction of two distinct proteins with cell type-specific expression.

Authors:  P Benech; G Merlin; M Revel; J Chebath
Journal:  Nucleic Acids Res       Date:  1985-02-25       Impact factor: 16.971

5.  Interferon action: two (2'-5')(A)n synthetases specified by distinct mRNAs in Ehrlich ascites tumor cells treated with interferon.

Authors:  G St Laurent; O Yoshie; G Floyd-Smith; H Samanta; P B Sehgal; P Lengyel
Journal:  Cell       Date:  1983-05       Impact factor: 41.582

6.  Immunological cross-reactivity between large and small (2'-5')oligoadenylate synthetases from pig cells.

Authors:  N Shimizu; Y Sokawa; J Sokawa
Journal:  J Biochem       Date:  1984-06       Impact factor: 3.387

7.  Continuous production of interferon in normal mice: effect of anti-interferon globulin, sex, age, strain and environment on the levels of 2-5A synthetase and p67K kinase.

Authors:  J Galabru; N Robert; C Buffet-Janvresse; Y Rivière; A G Hovanessian
Journal:  J Gen Virol       Date:  1985-04       Impact factor: 3.891

8.  Presence of (2'-5')oligoadenylate synthetase in avian erythrocytes.

Authors:  J Sokawa; N Shimizu; Y Sokawa
Journal:  J Biochem       Date:  1984-07       Impact factor: 3.387

9.  Structure of two forms of the interferon-induced (2'-5') oligo A synthetase of human cells based on cDNAs and gene sequences.

Authors:  P Benech; Y Mory; M Revel; J Chebath
Journal:  EMBO J       Date:  1985-09       Impact factor: 11.598

10.  Human 2-5A synthetase: characterization of a novel cDNA and corresponding gene structure.

Authors:  M E Saunders; D R Gewert; M E Tugwell; M McMahon; B R Williams
Journal:  EMBO J       Date:  1985-07       Impact factor: 11.598

View more
  26 in total

1.  Possible involvement of (2'5')oligoadenylate synthetase activity in pre-mRNA splicing.

Authors:  J Sperling; J Chebath; H Arad-Dann; D Offen; P Spann; R Lehrer; D Goldblatt; B Jolles; R Sperling
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

2.  Absence of the 40-kDa form of (2'-5')oligoadenylate synthetase and its corresponding mRNA from skin fibroblasts derived from Alzheimer disease patients.

Authors:  K K Khanna; S J An; J M Wu; S Landolfo; A G Hovanessian
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

Review 3.  A scientific journey through the 2-5A/RNase L system.

Authors:  Robert H Silverman
Journal:  Cytokine Growth Factor Rev       Date:  2007-07-27       Impact factor: 7.638

4.  Expression of heat shock protein 90 at the cell surface in human neuroblastoma cells.

Authors:  Cristina Cid; Ignacio Regidor; Pedro D Poveda; Alberto Alcazar
Journal:  Cell Stress Chaperones       Date:  2008-09-18       Impact factor: 3.667

Review 5.  RNase-L control of cellular mRNAs: roles in biologic functions and mechanisms of substrate targeting.

Authors:  Sarah E Brennan-Laun; Heather J Ezelle; Xiao-Ling Li; Bret A Hassel
Journal:  J Interferon Cytokine Res       Date:  2014-04       Impact factor: 2.607

6.  Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy.

Authors:  Antonella Sistigu; Takahiro Yamazaki; Erika Vacchelli; Kariman Chaba; David P Enot; Julien Adam; Ilio Vitale; Aicha Goubar; Elisa E Baracco; Catarina Remédios; Laetitia Fend; Dalil Hannani; Laetitia Aymeric; Yuting Ma; Mireia Niso-Santano; Oliver Kepp; Joachim L Schultze; Thomas Tüting; Filippo Belardelli; Laura Bracci; Valentina La Sorsa; Giovanna Ziccheddu; Paola Sestili; Francesca Urbani; Mauro Delorenzi; Magali Lacroix-Triki; Virginie Quidville; Rosa Conforti; Jean-Philippe Spano; Lajos Pusztai; Vichnou Poirier-Colame; Suzette Delaloge; Frederique Penault-Llorca; Sylvain Ladoire; Laurent Arnould; Joanna Cyrta; Marie-Charlotte Dessoliers; Alexander Eggermont; Marco E Bianchi; Mikael Pittet; Camilla Engblom; Christina Pfirschke; Xavier Préville; Gilles Uzè; Robert D Schreiber; Melvyn T Chow; Mark J Smyth; Enrico Proietti; Fabrice André; Guido Kroemer; Laurence Zitvogel
Journal:  Nat Med       Date:  2014-10-26       Impact factor: 53.440

7.  Interferon alters the pattern of secreted proteins from Ehrlich ascites-tumour cells.

Authors:  S Tominaga; K Tominaga
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

8.  RNase L plays a role in the antiviral response to West Nile virus.

Authors:  Svetlana V Scherbik; Jayashree M Paranjape; Bronislava M Stockman; Robert H Silverman; Margo A Brinton
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

9.  Effect of alpha interferon (IFN-alpha) on 2'-5' oligoadenylate synthetase activity in peripheral blood mononuclear cells of patients with chronic hepatitis C: relationship to the antiviral effect of IFN-alpha.

Authors:  J M Pawlotsky; A G Hovanessian; F Roudot-Thoraval; N Robert; M Bouvier; G Babany; J Duval; D Dhumeaux
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

10.  2',5'-Oligoadenylate-dependent RNAse located in nuclei: biochemical characterization and subcellular distribution of the nuclease in human and murine cells.

Authors:  B A Bayard; J B Gabrion
Journal:  Biochem J       Date:  1993-11-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.